Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-79.29	505.98	2443.68
Graham Fair Price	17.67	3.49	2.96
PEG	-17.47	0.42	-0.51
Price/Book	-7.24	0.98	1.05
Price/Cash Flow	37.36	-16.32	-26.05
Prices/Earnings	-30.69	15.25	22.00
Price/Sales	22.19	8.70	7.12
Price/FCF	37.36	-16.32	-26.05
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	53.55	0.13	0.09
Operating Margin	-84.90	-0.02	-0.01
ROA	31.21	< 0.005	< 0.005
ROE	0.01	0.02	33.83
ROIC	< 0.005	< 0.005	-40.62
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.01	0.08	-80.70
Dividends QOQ	-0.07	0.15	119.16
EBIT QOQ	-1.05	-0.43	59.41
EPS QOQ	-0.43	0.36	-16.02
FCF QOQ	-1.99	-0.51	74.55
Revenue QOQ	0.05	-0.23	382.26
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	27.38	53.41	95.05
Days Sales Outstanding (DSO)	1382.12	886.80	-35.84
Inventory Turnover	3.29	1.69	-48.73
Debt/Capitalization	0.82	0.82	-0.02
Quick Ratio	1.34	1.47	9.41
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	5.71	5.80	1.72
Cash	4.91	12.98	164.23
Capex	-0.62	-0.76	-22.47
Free Cash Flow	-0.23	-0.35	-50.63
Revenue	0.85	0.65	-22.78
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.57	1.64	4.68
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	1930.69	405.06	-79.02
Naive Interpretation	Member

06 - Financial Health · Weak

Rating